[시장보고서]세계의 레드 바이오테크놀러지 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별

세계의 레드 바이오테크놀러지 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별

Red Biotechnology Market, By Product Type, By Application, By End User, By Geography

상품코드 : 1741520

리서치사 : Coherent Market Insights

발행일 : 2025년 03월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,531,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000

￦ 10,159,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000

￦ 14,514,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

레드 바이오테크놀러지 시장은 2025년 9,102억 6,000만 달러, 2032년에는 1조 8,543억 8,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 10.7%를 나타낼 전망입니다.

보고서 범위		보고서 상세
기준 연도	2024	2025년 시장 규모	9,102억 6,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간(2025-2032년) CAGR	10.70%	2032년 가치 예측	1조 8,543억 8,000만 달러

레드 바이오테크놀러지는 의료 바이오테크놀러지로도 알려져 있으며, 의료 및 헬스케어 용도에 특화된 바이오테크놀러지의 하위 분야입니다. 질병 치료 및 예방을 위한 신약, 치료법, 의료 기술 개발에 생명공학 기술을 활용합니다.

시장 역학:

레드 바이오테크 시장은 몇 가지 요인에 의해 주도되고 있습니다. 고령화, 만성질환 증가, 팬데믹으로 인한 세계 헬스케어 수요 증가 등이 그것입니다. 유전체학, 개인 맞춤형 의료, 유전자 치료의 발전도 주요 촉진요인입니다. 또한, 정부 투자, 규제 당국의 지원, 민간 부문의 관심 증가도 혁신적인 치료법과 치료법을 개발하려는 레드 바이오테크놀러지의 성장에 기여하고 있습니다.

그러나 생물학적 제제의 의약품 개발과 관련된 높은 비용이 시장 성장을 억제할 것으로 예측됩니다.

본 조사의 주요 특징

세계의 레드 바이오테크놀러지(Red Biotechnology) 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사하여 정리한 보고서입니다.
또한, 다양한 부문에 걸친 잠재적 수익 기회를 파악하고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 레드 바이오테크놀러지 시장의 주요 기업을 프로파일링합니다.
이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
세계 레드 바이오테크 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 레드 바이오테크놀러지 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

Amgen Inc.
Gilead Sciences, Inc.
Biogen
Pfizer Inc.
Novartis AG
Hoffmann-La Roche
Johnson & Johnson Services, Inc.
Sanofi
Merck & Co. Inc.
AbbVie Inc.
GSK plc.
AstraZeneca
Eli Lilly and Company
Novo Nordisk A/S
Bayer AG
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim International GmbH
Astellas Pharma Inc.

제10장 섹션

조사 방법
출판사에 대해

LSH

영문 목차

영문목차

Red Biotechnology Market is estimated to be valued at USD 910.26 Bn in 2025 and is expected to reach USD 1,854.38 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 910.26 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.70%	2032 Value Projection:	USD 1,854.38 Bn

Red biotechnology, also known as medical biotechnology, is a subsector of biotechnology that focuses on medical and healthcare applications. It involves the use of biotechnology techniques to develop new drugs, therapies, and medical technologies for the treatment and prevention of diseases.

Market Dynamics:

Red biotechnology market is driven by several factors. These include the increasing global healthcare needs due to aging populations, rising chronic diseases, and pandemics. Advances in genomics, personalized medicine, and gene therapies are also key drivers. Additionally, government investments, regulatory support, and growing private sector interest contribute to the growth of red biotechnology, which aims to develop innovative medical treatments and therapies.

However, high costs associated with biologics drug development is expected to restrain the market growth.

Key features of the study:

This report provides in-depth analysis of the global red biotechnology market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global red biotechnology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Amgen, Gilead Sciences, Biogen, Pfizer, Novartis, Roche, Johnson & Johnson, Sanofi, Merck & Co., AbbVie, GlaxoSmithKline, AstraZeneca, Eli Lilly, Novo Nordisk, Bayer, Bristol-Myers Squibb, Teva Pharmaceutical, Takeda Pharmaceutical, Boehringer Ingelheim, and Astellas Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global red biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global red biotechnology market

Red Biotechnology Market Detailed Segmentation:

By Product Type
- Biopharmaceuticals
- Biosimilars
- Gene Therapy
- Tissue Engineering
- Cell Therapy
By Application
- Drug Discovery & Development
- Animal Biotechnology
- Environmental Biotechnology
- Medical Biotechnology
- Industrial Biotechnology
- Agricultural Biotechnology
- Others
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Research Institutes
- Biotechnology Industry
- Hospitals & Diagnostic Centers
- Academic Institutions
Company Profiles
- Amgen
- Gilead Sciences
- Biogen
- Pfizer
- Novartis
- Roche
- Johnson & Johnson
- Sanofi
- Merck & Co.
- AbbVie
- GlaxoSmithKline
- AstraZeneca
- Eli Lilly
- Novo Nordisk
- Bayer
- Bristol-Myers Squibb
- Teva Pharmaceutical
- Takeda Pharmaceutical
- Boehringer Ingelheim
- Astellas Pharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet , By End User
- Market Snippet , By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of chronic diseases
- Pricing pressures on biologics
- Biotech applications in agriculture
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Red Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Red Biotechnology Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Red Biotechnology Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Animal Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Environmental Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Medical Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Industrial Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Agricultural Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Red Biotechnology Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical & Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Biotechnology Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Hospitals & Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Red Biotechnology Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biogen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co. Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

한글목차

시장 역학:

본 조사의 주요 특징

목차

제1장 조사 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 세계의 레드 바이오테크놀러지 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

제5장 세계의 레드 바이오테크놀러지 시장, 제품 유형별, 2020-2032년

제6장 세계의 레드 바이오테크놀러지 시장, 용도별, 2020-2032년

제7장 세계의 레드 바이오테크놀러지 시장, 최종사용자별, 2020-2032년

제8장 세계의 레드 바이오테크놀러지 시장, 지역별, 2020년-2032년

제9장 경쟁 구도